Consolidated Statements Of Earnings (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Net sales	$ 2,389	$ 2,151	$ 7,057	$ 6,553
Cost of sales	822	682	2,399	2,125
Gross profit	1,567	1,469	4,658	4,428
Research, development and engineering expenses	153	136	461	397
Selling, general and administrative expenses	910	1,136	3,263	3,067
Intangible asset amortization	50	34	142	102
Restructuring charges	4	13	14	36
Total operating expenses	1,117	1,319	3,880	3,602
Operating income	450	150	778	826
Other income (expense), net	(25)	(13)	(79)	(45)
Earnings before income taxes	425	137	699	781
Income taxes	368	34	444	161
Net earnings	$ 57	$ 103	$ 255	$ 620
Net earnings per share of common stock:
Basic net earnings per share of common stock	$ 0.16	$ 0.27	$ 0.68	$ 1.64
Diluted net earnings per share of common stock	$ 0.16	$ 0.27	$ 0.67	$ 1.62
Weighted-average shares outstanding—in millions:
Basic	378.4	378.3	378.5	378.7
Net effect of dilutive employee stock options	4.1	3.4	4.2	3.1
Diluted	382.5	381.7	382.7	381.8
Anti-dilutive shares excluded from the calculation of net effect of dilutive employee stock options	0	0		1.9